Commit To Purchase Editas Medicine At $15, Earn 23.6% Annualized Using Options
January 19, 2017 at 13:21 PM EST
Investors considering a purchase of Editas Medicine Inc (EDIT) stock, but tentative about paying the going market price of $17.60/share, might benefit from considering selling puts among the alternative strategies at their disposal. One interesting put contract in particular, is the August put at the $15 strike, which has a bid at the time of this writing of $2.05..